US28106W1036
US28106W1036
Editas Medicine, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 40.520.000 | 32.314.000 | 25.4% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 139.856.000 | 271.234.000 | 48.4% | |
| Operating Income | -99.336.000 | -238.920.000 | 58.4% |
| Pretax Income | -160.060.000 | -237.093.000 | 32.5% |
| Net Income Common Stockholders | -160.060.000 | -237.093.000 | 32.5% |
| -- | -- | -- | |
| -- | -- | -- |